top of page
The Professional Network for Healthcare Experts
BeOne Medicines reaches US government agreement on cancer medicine access and pricing
BeOne Medicines has reached a voluntary agreement with the US government covering cancer medicine access, future pricing and continued investment in US pharmaceutical manufacturing.
nuaxia
Sep 22 min read
BeOne and Revolution Medicines partner on RAS-targeted oncology combinations and Asian licensing deal
The collaboration pairs BeOne’s oncology pipeline with four clinical-stage RAS(ON) inhibitors while giving BeOne regional rights to the Revolution Medicines assets across selected Asian markets.
nuaxia
Aug 123 min read
bottom of page